These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2960794)

  • 1. Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomolgus monkey.
    Schumacher WA; Goldenberg HJ; Harris DN; Ogletree ML
    J Pharmacol Exp Ther; 1987 Nov; 243(2):460-6. PubMed ID: 2960794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.
    Schumacher WA; Heran CL; Hartl KS; Ogletree ML
    J Pharmacol Exp Ther; 1990 May; 253(2):841-6. PubMed ID: 2140131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.
    Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ
    Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeys.
    Schumacher WA; Heran CL; Goldenberg HJ; Harris DN; Ogletree ML
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H726-34. PubMed ID: 2522282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
    Grover GJ; Schumacher WA
    J Pharmacol Exp Ther; 1989 Feb; 248(2):484-91. PubMed ID: 2521899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
    Valentin JP; Vieu S; Bertolino F; Fauré P; John GW
    J Pharmacol Exp Ther; 1997 Feb; 280(2):761-9. PubMed ID: 9023289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thromboxane receptor antagonists on venous thrombosis in rats.
    Schumacher WA; Heran CL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1109-15. PubMed ID: 2522985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thromboxane receptor blockade on oxygen supply/consumption variables during reperfusion in the anesthetized dog.
    Grover GJ; Sleph PG; Weiss HR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1097-102. PubMed ID: 2141635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
    Kopia GA; Kopaciewicz LJ; Ohlstein EH; Horohonich S; Storer BL; Shebuski RJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):887-95. PubMed ID: 2528630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane A2 in cardiovascular and renal disorders: is there a defined role for thromboxane receptor antagonists or thromboxane synthase inhibitors?
    Smith EF
    Eicosanoids; 1989; 2(4):199-212. PubMed ID: 2534279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis.
    Schumacher WA; Heran CL; Youssef S; Megill JR; Michel I; Durham SK
    Haemostasis; 1993; 23(4):219-28. PubMed ID: 8314172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the thromboxane A2-receptor antagonists, SQ 29,548 and SQ 28,668, on the pulmonary hypertensive response to endotoxemia in swine.
    Schumacher WA; Adams HD; Ogletree ML
    Pharmacology; 1987; 34(6):301-8. PubMed ID: 2958886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
    Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
    Azzam K; Cissé-Thiam M; Drouet L
    Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.